In honor of World Blindness Awareness Month, "GMA" is spotlighting a breakthrough gene therapy that's helping some blind ...
The U.S. Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
BioMarin no longer expects to hit its $4 billion revenue target by 2027, citing various market factors such as impending ...
Pharmaceutical Technology on MSN
Eli Lilly buys Adverum in eye disease gene therapy punt
Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...
ABC 11 Raleigh, NC on MSN
Duke Eye Center pioneers new gene therapy for rare eye disease
Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a ...
To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback